Abstract
Introduction
Gerstmann-Sträussler-Scheinker syndrome (GSS), first reported in 1936, as a common inherited prion disease, is clinically and genetically heterogeneous. 1, 2 According to a recent Japanese report, GSS102 accounts for 16.3% (93/572) of patients with inherited prion disease. 3 GSS102 is characterized clinically by prominent cerebellar signs accompanied by a slowly progressive dementia and pathologic findings of multifocal prion protein (PrP) -positive plaques. 4, 5 Spinocerebellar degeneration is known as one of the disease features and has been recognized as associated with dementia. However, dementia frequently appears later during the course of illness, which makes it difficult for neurologists to diagnose in the early
stage.
Previously, we demonstrated that GSS102 mainly shows ataxia of the lower limbs and trunk, dysarthria, lower limb paresthesia, and decreased deep tendon reflexes in the early stage, followed by dementia in the advanced stage. On radiologic analysis, we have also described that SPECT imaging shows abnormalities earlier than MRI, manifesting predominantly as decreased blood flow in the occipital lobes but almost normal flow in the cerebellum. 6 In this study, we further examined the higher brain function of patients wit h GSS102, and evaluated the image findings of MRI, SPECT, and PET.
Materials and Methods
We retrospectively studied five GSS patients from four families with genetically confirmed heterozygous Pro102Leu mutation in the PRNP gene. Additionally, 4 patients harbored homozygous methionine at codon 129 in PRNP, while heterozygous substitution from methionine to valine (Met129Val) was detected in patient 3. Besides, all patients shared a homozygous glutamate at codon 219. All patients were born in Kagoshima Prefecture, locating in the southern part of Japan. The protocol of the following study was reviewed and approved by the Institutional Review Board of Kagoshima University. All patients and family
A C C E P T E D M A N U S C R I P T members provided written, informed consents to participate in this study.
Cognitive and electrophysiological studies
Neurologic examination was performed mainly in our hospital. 
Radiological studies
Brain MRI (1.5T or 3.0T), N-isopropyl-p-[123I] iodoamphetamine SPECT, and 18F-2-fluoro-2-deoxy-D-glucose (18F-FDG) PET were performed in all patients during their initial examination. MRI, SPECT, and PET were performed within approximately one month in all patients. SPECT and PET were analyzed using the 3-dimensional stereotactic surface projection (3D-SSP) method. 7 Normalization was performed by whole-brain voxel averaging.
SPECT data from normal control subjects were obtained from sex-matched individuals of 60 to 69 years (13 cases) or of 70 to 79 (10 cases) years, applying standard measurements at National Center of Neurology and Psychiatry. Fluorodeoxyglucose (FDG)-PET scans in normal control subjects were based on standard measurements at Fujimoto General Hospital, and were obtained from 10 males and females at each age level. The stereotactic images were generated from 3D-SSP data using 3-dimensional brain scanning focus method software (Nihon-Mediphysics Co., Hyogo, Japan). We also analyzed quantities of blood flow and brain metabolism in each brain area using the stereotactic extraction estimation (SEE) method to detect details of small segments of the brain.
8

ACCEPTED MANUSCRIPT
A C C E P T E D M A N U S C R I P T
Results
Clinical and electrophysiological features
Five patients ranged from 59 to 73 years old, and their onset age were younger than 60 years, except for patient 1, who developed symptoms older than 70 years old. The period from onset to first examination ranged from 9 months to longer than 2 years. Initial symptoms varied significantly, encompassing lower limbs dysesthesia (1 case), ga it disturbance (2 cases), dysarthria (1 case), and character change (1 case). In the three patients who underwent electrophysiological studies, no notable abnormalities were found in NCS, needle EMG, or SSEP. In the EEG study, no periodic synchronous discharge, which was described in typical prion disease, was observed. The clinical and genetic features, higher brain functions, radiological and electrophysiological findings are summarized in Table 1 .
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Cognitive studies
Cognitive tests for patient 5 were not available because of his progressing dementia. We could not recognize any cognitive impairment through MMSE during initial neurologic examination in the other four patients. Decreased borderline intelligence was observed in patient 2 using the WAIS-R after she developed cognitive dysfunction. Further WAIS -R analysis suggested decreased long-termed memory by visuals in patient 1, and dysfunction of visual information processing in patient 2. With TMT, patient 1 showed a borderline decrease, while patient 2 had an obvious decrease. No remarkable abnormalities were identified in patients 3 and 4 by means of any cognitive tests. Their clinical courses are described in Figure 2 .
SPECT and FDG-PET analysis
SPECT analysis using 3D-SSP suggested decreased cerebral blood flow of the cortex in a mosaic-like pattern. All 5 patients showed a blood flow decrease in the anterior cingulate gyri, parahippocampal gyri, and thalamus. Patient 1 had a significant decrease in the frontal lobes, whereas a predominant decrease of blood flow in the occipital lobes was recognized in patients 1 and 2. Patients 3 and 4 showed more remarkable decrease of blood flow in cerebellum than others, particularly in the anterior lobes. Besides, patient 5 showed a more obvious blood flow decrease in the frontal lobes (Fig. 3 ).
Using FDG-PET, decreased glucose uptake of the cerebral cortex was observed in a mosaic pattern resembling SPECT findings. In three patients (patients 1, 2, and particularly 5)
FDG-PET revealed decreased glucose uptake in the frontal lobes. Besides, a remarkable decrease in glucose uptake was observed mainly in the precuneus of the posterior inside area in the parietal lobes. However, decreased glucose uptake in the cerebellum was only found in patient 3 and 4 (Fig. 4) .
We also evaluated SPECT and PET findings with the SEE method, and presented the
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proportion of voxel count which Z score was greater than 1.0 in each lobes of the cerebral cortex. SPECT analysis suggested predominantly decreased blood flow, most commonly in the occipital lobes, followed by the temporal and frontal lobes. PET analysis suggested predominantly decreased glucose uptake in the frontal lobes. Patient 5 with dementia showed decreased blood flow predominantly in the frontal lobes and grossly low glucose uptake (Fig.5) . Patients 1 and 2, whose disease was progressing, exhibited more evident glucose uptake decrease in the frontal lobes than other patients. Particularly, patient 2, who developed dementia earlier than other patients, exhibited a broader area of low glucose uptake.
By contrast, we could not recognize any significant reduction of blood flow in the cerebellum with SPECT analysis. However, further analysis with SEE showed a downward trend in the anterior lobes in 4 cases, suggesting a prominent difference from the cerebellar posterior lobes (Fig. 6 ). Furthermore, using PET analysis, we could only recognize significant hypometabolism in the cerebellum of Patient 3, which was further validated with SEE ( Fig.   6 ).
Discussion
We performed comprehensive radiologic analysis of five Japanese patients with GSS102. In patients with early stage GSS102, we found extensive hypometabolism in the cerebral cortex on FDG-PET analysis. We also identified a variety of involved regions in their cerebrum, which may lead to corresponding clinical diversity. Using SPECT analysis, we found new evidence for a downtrend of blood flow in the anterior cerebellar lobes, a projection field of the spinocerebellar tracts, which is an important feature of GSS.
Of the five patients, although their initial symptoms varied, neurologic findings revealed ataxia in lower limbs and trunk, dysesthesia in legs, and hyporeflexia/areflexia in lower limbs. The appearance order of clinical manifestations was different from each other in
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A C C E P T E D M A N U S C R I P T the present patients, whereas rapid progression followed by dementia was observed commonly. These clinical features were comparable to those of our previous report. 6 Patients 1 and 2, who exhibited abnormalities in brain MRI, suffered dementia and became bedridden in a short period after initial examination. For both patients, the WAIS-R study indicated deterioration of processing ability for information related to vision and ability of long-term memory. Meanwhile, TMT also indicated mild abnormal findings, but MMSE was normal.
These findings could account for abnormalities in their occipital lobes, where hypoperfusion and hypometabolism were identified in SPECT and PET, respectively.
In general, neuropathological examination suggest widespread spongiform change with numerous eosinophilic amyloid plaques (Kuru plaques) in the cerebral and cerebellar cortices. Numerous PrP immunopositive plaques and diffuse synaptic -type PrP deposition were extensively observed, particularly in the cerebral and cerebellar cortices. 9 A mosaic pattern decrease in cerebral blood flow and glucose uptake was identified through SPECT and PET image analysis, respectively. SPECT and PET were able to detect abnormalities earlier than brain MRI. FLAIR and DWI image (MRI) showed widespread cerebral cortica l hyperintensity. We only found obvious blood flow reduction in the frontal lobes of patient 5, who had dementia. Using PET analysis, we observed decreased glucose uptake at the anterior parts of the frontal and parietal lobes (superior parietal lobes, precuneus) in the cases with rapid progression of dementia (patients 1 and 2), or with recognized dementia (patient 5), which is correlated with the results of TMT. Discrepancies of findings between SPECT and PET might be associated with the difference in their sensitivity of disease progression. We could not recognize any atrophy and decreased blood flow in the thalamus in our patients, which was recent described in a GSS102 patient with long disease duration in Japan. 10 Further analysis of patients 1, 2, and 5, using PET and SEE, revealed that Brodmann area 46 was occupied with a number of Z-score > 1.0 voxels. These findings were clearly different from
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the other 2 patients (Fig. 5) residue might also result in clinical and radiological diversities. 9, 13 Although patient 3 was a typical GSS102 in clinic, a distinct trend of blood flow and metabolism was recognized in the cerebellum using both SPECT and PET (Fig.4, Fig.6 b) . We thus speculate that in a GSS102 
lobes than other patients, which might explain the dysarthria in addition to his lower limb ataxia. Additionally, it has been described that distribution of PrP deposits in the dorsal spinal horn was similar to that of presynaptic markers, and a decrease in Clarke's nucleus also was observed. 14 Further, the PrP accumulation, moving into synapses, also was reported in
Creutzfeld-Jakob disease of the brain. 15 We identified lower limb predominant ataxia in these patients, which might result from failure of transmission to the spinocerebellar tracts due to PrP deposits in the dorsal spinal horn, degeneration of spinocerebellar tracts, or cerebellar anterior lobes dysfunction.
Generally, FDG-PET is more sensitive compared to CBF -SPECT regarding synaptic activity of brain. Using SEE analyses, SPECT showed more significant hypoperfusion in the anterior cerebellar lobes in four patients, but FDG-PET showed hypometabolism in only one patient with Met129Val variant (Fig.6 ). The reason of this discrepancy is not clear and require further study. On the other hand, Patient 1 showed more significant hypometabolism of anterior cerebellar lobes (Fig.6 b) , and a similar tendency was observed on SPECT. This downtrend of blood flow in the anterior cerebellar lobes may be an important feature of GSS.
Peripheral neuropathy was sometimes suspected originally in the clinic because these patients presented with hyporeflexia or areflexia in the lower limbs, other than hyperreflexia, despite a pyramidal tract sign observed concurrently. No notable abnormality was observed in NCS and SSEP of patients 1 and 2, which indicated that their muscle weakness was associated with brain involvement. It has been proposed that the presence of lower limb areflexia without central and peripheral conduction abnormalities is highly suggestive or possibly pathognomonic of GSS102. 16 Deep tendon reflexes generally are a simple monosynaptic stimulation of alpha motor neurons through the Ia fibers, which is evoked by the muscle spindle stimulated by extension of the muscle. Deposits of PrP were found predominantly in the dorsal horn, particularly in the lumbar spinal cord and substantia gelatinosa containing Areas with low glucose uptake are indicated. Areas with Z scores greater than 2 had a statistically significant decrease in glucose uptake. A C C E P T E D M A N U S C R I P T 
